👉 Asemeia is a type of biomarker that uses DNA methylation patterns in cells to detect cancerous or malignant tumors. It involves identifying specific DNA modifications (e.g., histone modifications) that are altered in response to certain stimuli, such as exposure to radiation or chemotherapy. By measuring these changes in the methylation levels, researchers can identify which cells are more susceptible to growth and proliferation, potentially leading to a better prognosis for cancer patients.
